Last checked at 
LONDON (Alliance News) - Medical devices firm Tissue Regenix Group PLC said on Thursday that Chief Executive Officer Steve Couldwell will take a leave of absence from January due to ill health in order to undergo medical treatment.
The leave is expected to last for the first quarter of 2019.
During his absence, Chair John Samuel will become executive chairman, and Chief Financial Officer Gareth Jones will become chief operating officer, both on an interim basis.
"Steve has done an excellent job of establishing a sound business strategy and delivering positive sales momentum. We are confident we will continue to execute against this strategy and on behalf of the board and everyone at Tissue Regenix, I wish Steve a full and speedy recovery," Samuel said.
In addition, Tissue Regenix said current trading for 2018 remains in line with expectations.
Shares in Tissue Regenix were untraded on Thursday, last quoted at 6.92 pence.
